Clinical Trials Browser

Phase 2/3 × Completed × Adenocarcinoma × Clear all

NCT01249352 2025-03-31

NICE

Phase 2/3 Completed

Gastrointestinal

Adenocarcinoma, Esophageal Neoplasms

NCT01404156 2024-08-28

POWERRANGER

Phase 2/3 Completed

Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms

NCT00443196 2018-03-12

Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas

Phase 2/3 Completed

Adenocarcinoma, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT00827554 2016-04-01

The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma

Phase 2/3 Completed

Gastrointestinal

Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms

NCT00127478 2007-11-29

A Long Term Safety Study With Atrasentan

Phase 2/3 Completed

Adenocarcinoma, Prostatic Neoplasms